Evidence map›Paper›PMID 39201021›Full record

ReviewJournal of clinical medicine2024

Current Role of PET CT in Staging and Management of Penile Cancers.

Cristian Mirvald, Radion Garaz, Ioanel Sinescu, Adrian Preda, Apostolos Labanaris, Ofer Yossepowitch, Igor Tsaur, Cristian Surcel

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cristian MirvaldDepartment of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.ORCID 0000-0002-7278-5551
Radion GarazDepartment of Urology, University Hospital Tübingen, 72076 Tübingen, Germany.
Ioanel SinescuDepartment of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Adrian PredaDepartment of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Apostolos LabanarisDepartment of Urology, Interbalkan Medical Center, 57001 Thessaloniki, Greece.
Ofer YossepowitchDepartment of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel.
Igor TsaurDepartment of Urology, University Hospital Tübingen, 72076 Tübingen, Germany.ORCID 0000-0001-5107-3523
Cristian SurcelDepartment of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penile cancer (PeCa) is a rare urological malignancy characterized by significant geographical variations in both incidence and mortality rates. Due to its rarity and the consequent lack of randomized trials, current management is based on retrospective studies and small prospective trials. In addition, both the diagnostic pathways and treatment strategies exhibit substantial heterogeneity, differing significantly between less-developed and well-developed countries. The prognosis of PeCas is determined by the presence and extent of regional lymph node (LN) involvement. Therefore, the early detection and treatment of LN metastasis is paramount to ensure better outcomes. In recent decades, overall survival of PeCas has increased, mainly due to advancements in imaging techniques and risk stratification. We aim to provide an overview of the current role of PET CT imaging in the management of patients with PeCa.

Indexed as

lymph nodespenile cancerPET CTsentinel node biopsy

Identifiers

PMID39201021
PMCPMC11355205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.